Publications for Elisabet Lundborg
Co-author map based on ISI articles 2007-

Publications mentioned in social media 13 times*

Journal Articles

Martin Henriksson, Elisabet Nikolic, Audun Ohna, Lars Wallentin and Magnus Janzon
  Ticagrelor treatment in patients with acute coronary syndrome is cost-effective in Sweden and Denmark
 
Altmetric usage: 3

  Scandinavian Cardiovascular Journal, 2014, 48(3), 138-147.

Elisabet Nikolic, Magnus Janzon, Ole Hauch, Lars Wallentin and Martin Henriksson
  Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study
 
Altmetric usage: 10

  European Heart Journal, 2013, 34(3), 220-228.
 Web of Science® Times Cited: 18

L. Delgado-Ortega, J. L Lopez-Sendon, M. Heras Fortuny, C. Alvarez Sanz, Elisabet Nikolic, C. Mellström and L Wallentin
  PCV45 Health Economic Evaluation of Ticagrelor in Patients with Acute Coronary Patients (ACS) Based on the Plato Study from A Spanish Health Care Perspective
  Value in Health, 2011, 14(7), A372-A372.
 Web of Science® Times Cited: 1

Jeanette Wahlberg, Jenny Fredriksson (Walldén), Elisabet Nikolic, Outi Vaarala and Johnny Ludvigsson
  Environmental factors related to the induction of beta-cell autoantibodies in 1-yr-old healthy children
  Pediatric Diabetes, 2005, 6(4), 199-205.
 Web of Science® Times Cited: 7

Matthias Pulz, Andreas Matussek, Masyar Monazahian, Andreas Tittel, Elisabet Nikolic, Maike Hartmann, Tobias Bellin, Jan Buer and Florian Gunzer
  Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens
  Journal of Clinical Microbiology, 2003, 41(10), 4671-4675.
 Web of Science® Times Cited: 28

Conference Articles

Kari Johansen, M. Brytting, Magnus Husberg, Elisabet Lundborg (Nikolic), A.N. Tran, R. Bennet, M. Eriksson and Per Carlsson
  Estimates of Healthcare and Non-Healthcare Costs due to Severe Rotavirus Infections leading to Hospitalization in Swedish Children (<5 years)
  ESPID 2011, The Hague, The Netherlands, June 7-11, 2011, 2011.


M. Henriksson, Elisabet Nikolic, Magnus Janzon, O. Hauch, Lars-Åke Levin and L. Wallentin
  LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDY in VALUE IN HEALTH, vol 14, issue 3, pp A40-A40
  VALUE IN HEALTH, 2011.


 Web of Science® Times Cited: 2

Magnus Janzon, Elisabet Nikolic, Martin Henriksson, Lars-Åke Levin, Ole Hauch, DB Mark, P. Cowper, P. Kaul, RA. Harrington, J. Horrow and Lars Wallentin
  Health Economics in the PLATelet Inhibition and Patient Outcomes (PLATO) Randomized Trial: Report on Within Trial Resource Use Patterns
  The American Heart Association 2010 Scientific Sessions, Chicago, IL, USA, November 13-17 2010, 2010.


Martin Henriksson, Magnus Janzon, M. Aasa, Elisabet Lundborg (Nikolic), L. Svensson, J. Herlitz, L. Grip and Lars-Åke Levin
  Cost-effectiveness of very early treatment strategies for acute ST-elevation myocardial infarction based on the Swedish early decision (SWEDES) reperfusion trial (oral presentation)
  SMDM Europe,2008, 2008.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.